DESIGN, FORMULATION AND EVALUATION OF TRANSDERMAL DRUG DELIVERY SYSTEM OF BUDESONIDE

被引:0
|
作者
Amgaokar, Yogesh M. [1 ]
Chikhale, Rupesh V. [1 ]
Lade, Updesh B. [1 ]
Biyani, Dinesh M. [1 ]
Umekar, Milind J. [1 ]
机构
[1] Smt Kishoritai Bhoyar Coll Pharm, Dept Pharmaceut, Nagpur, MS, India
关键词
Transdermal drug delivery; Budesonide; corticosteroid; IN-VIVO EVALUATION; PHARMACOLOGICAL-PROPERTIES; THERAPEUTIC-EFFICACY; VITRO; PROPRANOLOL; DICLOFENAC; RHINITIS;
D O I
暂无
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Budesonide is a highly potent synthetic, nonhalogenated corticosteroid. The mechanism of action of corticosteroids in allergic rhinitis remains unknown, but may involve reductions in number of various mediator cells such as basophils, eosinophils, T-helper cells, mast cells, and neutrophils. In the nasal mucosa, nasal reactivity to allergens, and release of inflammatory mediators and proteolytic enzymes. Budesonide is very effective and quikly acting as it is rapidly and almost completely absorbed after oral administration, but has poor systemic availability (about 10%) due to extensive first-pass metabolism in the liver, mainly by the cytochrome P450 isoenzyme CYP3A4.. The major metabolites, 6-beta-hydroxybudesonide and 16-alpha-hydroxyprednisolone have less than 1% of the glucocorticoid activity of unchanged drug with a terminal half-life of about 2-4 hours. Polymeric films containing Eudragit RL 100: Eudragit RS: drug (7:3:1, 7:2:1) and Ethyl cellulose: PVP: drug (7:3:1, 7:2:1) were selected for transdermal administration based on evaluation studies. These polymeric films were prepared by mercury substrate method employing PEG-400 as plasticizer. Two different penetration enhancers Urea and Dimethyl sulphoxide (DMSO) were employed in the study. The patches in each group were uniform in drug content, thickness. In Vitro drug permeation, moisture absorption and WVTR studies were carried out on these test patches. It was found that at all humidity condition the absorption increases which were linear to the moisture absorbed. In PVA and EUDRAGIT RL 100 patches the water vapor transmission rate was found to be higher at 75% RH, RT conditions. Therefore at both % RH, RT condition the PVA and EUDRAGIT RL 100 patches provides the best resistance to water vapor. Therefore, when applied to animals (in further studies) these patches may provide more occlusion to water vapor loss from skin thus making atmosphere beneath the skin more humid that aid in drug permeation.
引用
收藏
页码:475 / 497
页数:23
相关论文
共 50 条
  • [41] Formulation and evaluation of transdermal nanogel for delivery of artemether
    Nnamani, Petra O.
    Ugwu, Agatha A.
    Nnadi, Ogechukwu H.
    Kenechukwu, Franklin C.
    Ofokansi, Kenneth C.
    Attama, Anthony A.
    Lehr, Claus-Michael
    [J]. DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2021, 11 (04) : 1655 - 1674
  • [42] Formulation and Evaluation of Ethosomes for Transdermal Delivery of Lamivudine
    Jain, Subheet
    Tiwary, Ashok K.
    Sapra, Bharti
    Jain, Narendra K.
    [J]. AAPS PHARMSCITECH, 2007, 8 (04)
  • [43] Modified Diffusion Apparatus for Evaluation of Transdermal Drug Delivery System
    Gohel, M. C.
    Parikh, R. K.
    Delvadia, R. R.
    Nagori, S. A.
    Sarvaiya, K. G.
    Patel, B. H.
    Patel, V. P.
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2009, 43 (02) : 134 - 139
  • [44] Transdermal delivery of salbutamol sulphate: Formulation and evaluation
    El-Gendy, Nashwa A.
    Sabry, Nirmeen A.
    El-Attar, Mai
    Omar, Emad
    Mahmoud, Manal
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2009, 14 (02) : 216 - 225
  • [45] Formulation and evaluation of ethosomes for transdermal delivery of lamivudine
    Subheet Jain
    Ashok K. Tiwary
    Bharti Sapra
    Narendra K. Jain
    [J]. AAPS PharmSciTech, 8
  • [46] Formulation and evaluation of transdermal nanogel for delivery of artemether
    Petra O. Nnamani
    Agatha A. Ugwu
    Ogechukwu H. Nnadi
    Franklin C. Kenechukwu
    Kenneth C. Ofokansi
    Anthony A. Attama
    Claus-Michael Lehr
    [J]. Drug Delivery and Translational Research, 2021, 11 : 1655 - 1674
  • [47] Formulation and evaluation of ubidecarenone transdermal delivery systems
    Jung, Sun Young
    Kang, Eun Young
    Choi, Yoon Jung
    Chun, In Koo
    Lee, Byung Koo
    Gwak, Hye Sun
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (09) : 1029 - 1034
  • [48] Formulation and evaluation of fluvastatin sodium drug-in-adhesive transdermal system
    Geevarghese, Rachel
    Shirolkar, Satish
    [J]. JOURNAL OF RESEARCH IN PHARMACY, 2020, 24 (04): : 562 - 571
  • [49] Development and evaluation of a drug-in-adhesive transdermal delivery system for delivery of olanzapine
    Vora, Deepal
    Banga, Ajay K.
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2022, 19 (11) : 1539 - 1548
  • [50] DEVELOPMENT OF A NOVEL FORMULATION FOR TRANSDERMAL DELIVERY OF AN ANTIDEPRESSANT DRUG
    Negi, Purnima
    Ahmad, Farhan J.
    Ahmad, Dabeer
    Jain, Gaurav K.
    Singh, Gyanendra
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2011, 2 (07): : 1766 - 1771